SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-287348
Filing Date
2017-09-18
Accepted
2017-09-18 16:27:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d413206d424b5.htm 424B5 641099
2 GRAPHIC g413206g57i48.jpg GRAPHIC 22171
  Complete submission text file 0001193125-17-287348.txt   672945
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-206539 | Film No.: 171090154
SIC: 2834 Pharmaceutical Preparations